lobbying_activities: 1558140
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1558140 | c05aa05b-e284-4fc7-9766-cb833bd8b616 | Q2 | ALKERMES, INC. | 400458235 | ALKERMES, INC. | 2014 | second_quarter | PHA | DEA regulatory transparency in controlled substances scheduling person DEA regulatory transparency in issuing research licenses and quotas | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute on Alcohol Abuse & Alcoholism (NIAA),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE | 553600 | 0 | 0 | 2014-07-18T08:46:16.857000-04:00 |